In this Issue
Interventional strategies aimed at limb salvage and preventing amputation.
Amputation Prevention: We’ve Only Just Begun…
By Jihad A. Mustapha, MD, FACC, FSCAI, and John R. Laird, MD
The right equipment can make all the difference in successful procedural outcomes.
By Gary M. Ansel, MD
Utilizing ultrasound-guided access, IVUS, and OCT to deliver current state-of-the-science endovascular treatments for patients with critical limb ischemia.
By Jihad A. Mustapha, MD, FACC, FSCAI; Fadi Saab; Larry J. Diaz-Sandoval, MD; and Barbara Karenko, DO
Recommendations on how to successfully cross chronic total occlusions of the infrapopliteal vasculature.
By George L. Adams, MD, MHS, FACC; Steve J. Gardner, BA; Jon Gardner, MBA, RCIS, CCVT, CCPT; and Jihad A. Mustapha, MD, FACC, FSCAI
Technical pearls and new devices for crossing peripheral CTOs.
By Usman Javed, MD, and John R. Laird, MD
What is the role of this technology in diabetic macroangiopathy and complex infrapopliteal interventions?
By Lanfroi Graziani, MD
A look at devices in use or under investigation for treating CLI patients with complex lesions.
By Robert M. Bersin, MD, FSCAI, FACC
This underutilized test may provide critical insights into patients’ health.
By Raghotham Patlola, MD, FACC, and Craig Walker, MD, FACC
A case report illustrating the successful management of multilevel complex peripheral vascular lesions using a hybrid technique.
By Tracy N. Huynh, MD; Akhilesh K. Jain, MD; Jeffrey E. Indes, MD, FACS; and Carlos Mena-Hurtado, MD, FACC, FSCAI
Do arterial and venous disease overlap in patients with tissue loss?
By Jose I. Almeida, MD, FACS, RPVI, RVT, and Cristal Boatright, MMS, PA-C
With Sean P. Lyden, MD, FACS; Jos C. van den Berg, MD, PhD; Lawrence A. Garcia, MD, FACC, FAHA, FSCAI; Robert Lookstein, MD, FSIR, FAHA; Edward Y. Woo, MD; Mahmood Razavi, MD; Malcolm T. Foster III, MD, FACC; and John H. Rundback, MD
Prevention of in-stent restenosis is currently a utopian ideal, but a handful of trials and growing clinical experience are showing that better treatment options may be on the horizon.
By Jos C. van den Berg, MD, PhD
Endovascular Today talks to vascular surgeon Dr. Lombardi about device decisions, patient management, and the 2012 International Aortic Summit.